Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
Therapeutic Agents for Metabolic-Associated Steatohepatitis and Liver Fibrosis (MASH-TAG 2025)
Association Between Fibrosis-4 (FIB-4) Index and Major Adverse Liver Outcomes in Patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Retrospective Cohort Study
Therapeutic Agents for Metabolic-Associated Steatohepatitis and Liver Fibrosis (MASH-TAG 2025)
:
Download poster (.pdf)
